神經血管導管市場規模、佔有率及成長分析（按類型、組件、應用、最終用途和地區分類）－2026-2033年產業預測

預計到 2024 年，神經血管導管市場規模將達到 34.8 億美元，到 2025 年將達到 37.3 億美元，到 2033 年將達到 65.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.2%。

神經血管導管市場正經歷顯著成長，其主要促進因素包括腦動脈瘤和中風等神經系統疾病發病率的上升、生活方式的改變以及公眾對治療方案認知的提高。此外，可支配收入的增加和市場領導不斷推出創新產品也進一步推動了這一成長。蛛網膜下腔出血發生率的上升凸顯了市場的巨大需求，尤其是在新興市場承擔了相當一部分病例的情況下。導管設計的技術進步也預計將促進市場動態，例如新一代球囊引導管等創新技術將拓展急性缺血性腦中風的治療選擇。對各種神經血管通路技術的全面研究有助於臨床療效和效率的持續提升，從而進一步推動市場成長。

神經血管導管市場促進因素

包括中風、動脈瘤和動靜脈畸形（AVM）在內的神經系統疾病發生率不斷上升，顯著推動了對神經血管導管的需求。隨著這些疾病的日益普遍，對有效診斷和治療方案的需求也日益成長，使得神經血管導管成為醫療領域不可或缺的工具。這些專用器械對於醫務人員準確診斷和治療此類複雜疾病患者至關重要。因此，人們對解決神經系統健康問題的日益關注預計將繼續推動神經血管導管市場的發展，這體現了這些器械在現代醫學中的關鍵作用。

限制神經血管導管市場的因素

神經血管導管市場面臨許多限制因素，主要源自於腦內複雜血管系統的進入與操作本身就極具挑戰性。這種複雜性增加了出血、血栓形成、血管穿孔和感染等嚴重併發症的風險，這些併發症可能造成毀滅性後果，包括急性神經功能障礙甚至死亡。此外，這些併發症往往會導致住院時間延長和醫療成本增加。過去有健康問題的患者發生不利事件的風險更高，這進一步加劇了神經血管導管插入術的整體風險，從而影響市場動態。

神經血管導管市場趨勢

受中風、動脈瘤和動靜脈畸形等神經系統疾病發病率上升的推動，神經血管導管市場正經歷顯著成長。隨著醫療機構日益尋求有效且微創的治療方案，創新導管技術正獲得廣泛應用。醫療基礎設施的進步以及人口老化加劇了這一趨勢，因為老齡化人口更容易患上這些疾病。此外，持續的研發工作不斷改善導管的設計和功能，從而改善患者預後並提高手術效率。因此，神經血管領域的相關人員已做好充分準備，把握市場對專用導管日益成長的需求，以應對這些重要的醫療挑戰。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 專利分析

全球神經血管導管市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 微導管
• 球囊導管
• 導管接入
• 栓塞導管
• 其他

全球神經血管導管市場規模（按組件分類）及複合年成長率（2026-2033 年）

• 導管芯軸
• 導管襯墊
• 重新加熱熱縮管
• 尼龍管/Pebax
• 其他部分

全球神經血管導管市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 栓塞性中風
• 腦動脈瘤
• 動靜脈畸形
• 其他

全球神經血管導管市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院
• 診所
• 門診手術中心
• 診斷中心

全球神經血管導管市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Medtronic（Galway, Ireland）
• Boston Scientific（Marlborough, Massachusetts, USA）
• Stryker Corporation（Kalamazoo, Michigan, USA）
• Penumbra（Alameda, California, USA）
• Edwards Lifesciences（Irvine, California, USA）
• Terumo Corporation（Tokyo, Japan）
• Johnson & Johnson（New Brunswick, New Jersey, USA）
• Abbott Laboratories（Abbott Park, Illinois, USA）
• B. Braun Melsungen（Melsungen, Germany）
• MicroPort Scientific（Shanghai, China）
• Integer Holdings Corporation（Plano, Texas, USA）
• Cook Medical（Bloomington, Indiana, USA）
• Cardinal Health（Dublin, Ohio, USA）
• Smith & Nephew（London, United Kingdom）
• Teleflex Incorporated（Wayne, Pennsylvania, USA）
• Merit Medical Systems（South Jordan, Utah, USA）
• Nipro Corporation（Osaka, Japan）
• Asahi Intecc（Aichi, Japan）
• WL Gore & Associates（Newark, Delaware, USA）
• Convatec（London, United Kingdom）

結論與建議

Neurovascular Catheters Market size was valued at USD 3.48 Billion in 2024 and is poised to grow from USD 3.73 Billion in 2025 to USD 6.51 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The neurovascular catheter market is experiencing significant growth driven by the increasing incidence of neurological disorders such as brain aneurysms and strokes, coupled with lifestyle changes and enhanced public awareness regarding treatment options. Additionally, rising disposable incomes and the continuous introduction of innovative products by market leaders further propel this expansion. The prevalence of subarachnoid hemorrhage highlights a substantial market need, particularly as emerging markets bear a significant portion of this burden. Technological advancements in catheter designs are also expected to contribute to market dynamics, with innovations like next-generation balloon guide catheters enhancing treatment options for acute ischemic strokes. Comprehensive research into various neurovascular access methods supports continued improvement in clinical outcomes and efficiency, further fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Catheters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Catheters Market Segments Analysis

Global Neurovascular Catheters Market is segmented by Type, Component, Application, End-use and region. Based on Type, the market is segmented into Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters and Others. Based on Component, the market is segmented into Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax and Other Components. Based on Application, the market is segmented into Embolic Stroke, Brain Aneurysm, Arteriovenous Malformations and Others. Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Catheters Market

The increasing incidence of neurological conditions, including strokes, aneurysms, and arteriovenous malformations (AVMs), is significantly fueling the demand for neurovascular catheters. As these disorders become more common, the need for effective diagnostic and therapeutic solutions grows, making neurovascular catheters essential tools in medical practice. These specialized devices are crucial for enabling healthcare professionals to accurately diagnose and treat patients suffering from such complex conditions. Consequently, the heightened focus on addressing neurological health concerns is expected to continue driving the expansion of the neurovascular catheters market, reflecting the critical role these instruments play in modern healthcare.

Restraints in the Neurovascular Catheters Market

The neurovascular catheters market faces significant constraints primarily due to the inherent challenges of accessing and maneuvering through the intricate blood vessels in the brain. This complexity raises the potential for serious complications, including bleeding, clot formation, vessel perforation, and infection, which can have dire consequences such as acute neurological deficits or mortality. Furthermore, these complications often result in extended hospital stays and elevated healthcare expenses. The risk of adverse effects escalates in individuals with pre-existing health issues, compounding the overall risks associated with neurovascular catheter procedures and thereby influencing the market dynamics.

Market Trends of the Neurovascular Catheters Market

The neurovascular catheters market is experiencing significant growth, fueled by the rising prevalence of neurological disorders, including strokes, aneurysms, and arteriovenous malformations. As healthcare providers increasingly seek effective and minimally invasive treatment solutions, innovative catheter technologies are gaining traction. This trend is further supported by advancing healthcare infrastructure and a growing aging population susceptible to such ailments. Additionally, ongoing research and development efforts are enhancing catheter designs and functionalities, improving patient outcomes and procedural efficiency. Consequently, stakeholders in the neurovascular space are poised to capitalize on the heightened demand for specialized catheters to address these critical healthcare challenges.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Neurovascular Catheters Market Size by Type & CAGR (2026-2033)

• Market Overview
• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Global Neurovascular Catheters Market Size by Component & CAGR (2026-2033)

• Market Overview
• Catheter Mandrels
• Catheter Liners
• Reflow Heat Shrinks
• Nylon Tubing/Pebax
• Other Components

Global Neurovascular Catheters Market Size by Application & CAGR (2026-2033)

• Market Overview
• Embolic Stroke
• Brain Aneurysm
• Arteriovenous Malformations
• Others

Global Neurovascular Catheters Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Neurovascular Catheters Market Size & CAGR (2026-2033)

• North America (Type, Component, Application, End-use)
  • US
  • Canada
• Europe (Type, Component, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Component, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Component, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Component, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Galway, Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (Marlborough, Massachusetts, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (Kalamazoo, Michigan, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (Alameda, California, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (Irvine, California, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Tokyo, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (New Brunswick, New Jersey, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Abbott Park, Illinois, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen (Melsungen, Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (Shanghai, China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (Plano, Texas, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (Bloomington, Indiana, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (Dublin, Ohio, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (London, United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (Wayne, Pennsylvania, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (South Jordan, Utah, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Osaka, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc (Aichi, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates (Newark, Delaware, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec (London, United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations